Korelasi Skor Gleason dengan Kadar Prostat Spesifik Antigen (PSA) Pada Pasien Karsinoma Prostat
Abstract
Prostatic carcinoma is malignancy of the prostate gland which is found in inferior portion of the bladder and anterior part of the rectum. To diagnose prostatic carcinoma, required Prostate Specific Antigen (PSA) levels and Gleason Score examination. PSA is an important marker serum for prostatic carcinoma. While the Gleason score is used to determine the differentiation degree and confirm the diagnosis of prostatic carcinoma. Objectives: This study was conducted to determine the correlation between PSA level with Gleason score in patients with prostatic carcinoma at Gatot Soebroto Army Hospital in period 2015-2016. Methods: The type of this study was analitic observational by cross sectional approach and consecutive sampling method with 60 subjects. The data was analyzed by using Spearman correlation test. Results: This study proved that there was a correlation between PSA level with Gleason score (p = 0,012; r = 0,321). Conclusions: PSA level had a relation to Gleason score.
Keywords
Full Text:
PDFReferences
International Agency for Research on Cancer. World cancer report. Lyon; 2014 [Disitasi pada 2017 Sep 3] Tersedia di:
http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014
American Cancer Society. Cancer Facts and Figures. Atlanta; 2014 [Disitasi pada 2017 Sep 3] Tersedia di:
https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2014.html
Global Burden Cancer. Cancer Fact Sheets: prostate cancer. Lyon; 2012 [Disitasi pada 2017 Sep 3] Tersedia di: http://globocan.iarc.fr/old/FactSheets/cancers/prostate-new.asp
World Health Organization. Prostate Cancer in Indonesia. USA; 2014 [Disitasi pada 2017 Sep 3] Tersedia di: http://www.worldlifeexpectancy.com/indonesia-prostate-cancer
Akaza H, Hinotsu S, Cooperberg MR. Sixth joint meeting of J-CaP and CaPSURE-a multinational perspective on prostate cancer management and patient outcomes. Japan Journal Clinical Oncology; 2013 [Disitasi pada 2017 June 4]; 43; 56-66. Tersedia di:
https://www.ncbi.nlm.nih.gov/pubmed/23723314
Ikatan Ahli Urologi Indonesia. Panduan Penatalaksanaan Kanker Prostat. Jakarta; 2011 [Disitasi pada 2017 June 4]. Tersedia di:
http://kanker.kemkes.go.id/guidelines/PPKProstat.pdf.
Kirby R, Fitzpatrick J. Prostate-Specific Antigen Testing for the Early Detection of Prostate Cancer. BJU International; 2014 [Disitasi pada 2018 Feb 7]; 94(7); 966-967. Tersedia di:
https://onlinelibrary.wiley.com/doi/full/10.1111/j.1464410X.2004.05085.x
Zhou M, Galluzi CM. Genitourinary Pathology: Neoplasms of the Prostate and Seminal Vesicles. Philadelphia Elsevier; c2007.
Pourmand G, Gooran S, Hossieni SR, Guitynavard F, Safavi M, Sharifi A, Mokhtari E. Correlation of Preoperative and Radical Prostatectomy Gleason Score: Examining the Predictors of Upgrade and Downgrade Results. Acta Medica Iranica; 2017 [Disitasi pada 2018 Jan 15]; 55(4); 249-253. Tersedia di: https://www.ncbi.nlm.nih.gov/pubmed/28532136
Lojapinawat B, Wisan A, Wilaiwan C, Chaichawan U. Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice. Prostate International; 2014 [Disitasi pada 2018 Jan 15]; 2(3); 133-139. Tersedia di: https://www.ncbi.nlm.nih.gov/pubmed/25325025
Amarneel S, Gohil RM, Parmar NK, Gamit S, Vala M, Shukla D. Study of Serum Prostate Specific Antigen Level in Prostate Biopsy Specimens. International Journal of Innovative Researh and Development; 2015 [Disitasi pada 2017 June 6]; 4(6); 176-179. Tersedia di:
http://www.ijird.com/index.php/ijird/article/download/71944/56041
Gurumurthy D, Maggad R, Patel S. Prostate carcinoma: correlation of histopathology with serum prostate specific antigen. Science Journal of Clinical Medicine; 2015 [Disitasi pada 2018 Feb 8]; 4; 1-5. Tersedia di:
http://article.sciencepublishinggroup.com/html/10.11648.j.sjcm.s.2015040401.11.html
American Cancer Society. Prostate Cancer Risks Factors. Atlanta; 2016 [Disitasi pada 2017 Sep 3]. Tersedia di:
http://www.cancer.org/cancer/prostate-cancer/causes-risks-prevention/risk-factors.html
Solang VR, Monoarfa A, Tjandra F. Profil penderita kanker prostat di RSUP Prof. Dr. R. D. Kandou Manado periode tahun 2013–2015. Jurnal e-Clinic (eCl); 2016 [Disitasi pada 2018 Feb 7]; 4(2). Tersedia di:
http://ejournal.unsrat.ac.id/index.php/eclinic/article/download/14371/13943
World Cancer Research Fund International. Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Prostate Cancer. Prostate Cancer Report; 2014 [Disitasi pada 2018 Feb 24]; 1-48. Tersedia di: https://www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf.
Junaidi F. Hubungan antara grading histopatologi (Gleason score) dan level PSA kanker prostat di Rumah Sakit Umum Pusat H. Adam Malik Medan. Tesis Fakultas Kedokteran Universitas Sumatera Utara Medan. 2012 [Disitasi pada 2017 Des 25]. Tersedia di:
http://repository.usu.ac.id/handle/123456789/34209
Mochtar CA, Atmoko W, Umbas R. Prostate cancer detection rate in Indonesian men. Asian Journal of Surgery;2017 [Disitasi pada 2018 Feb 8]; 1-7. Tersedia di:
http://www.ncbi.nlm.nih.gov/pubmed/28209461
Erlangga D. Ketepatan diagnostik Prostate Specific Antigen pada Keganasan Prostat di RS Dr. Kariadi Semarang. Skripsi Fakultas Kedokteran Universitas Diponegoro Semarang. 2007 [Disitasi pada 2018 Feb 8]. Tersedia di: http://eprints.undip.ac.id/22323/1/Dimas.pdf
Myh E, Umbas R, Mochtar CA, Santoso RB. Prostate Specific Antigen (PSA) Inisial ≥ 100 ng/ml Menggambarkan Stadium Lanjut dan Rendahnya Survival Kanker Prostat. Indonesian Journal of Cancer; 2011 [Disitasi pada 2018 Feb 8]; 5(2); 57-60. Tersedia di:
https://media.neliti.com/media/publications/70047-ID-prostate-specific-antigen-psa-inisial-10.pdf
Masaki S, Noriaka T, Takehiro K, Daisuka Y, Keisuke T, Takashi N. Clinical study of prostate cancer with a PSA level of more than 100 ng/ml at the first hospital visit. Nishinihon Journal Urology; 2007 [Disitasi pada 2018 Feb 6]; 69; 1-5. Tersedia di:
https://www.researchgate.net/publication/288402891_Clinical_study_of_prostatic_cancers_with_a_PSA_level_of_more_than_100_ngml_at_the_first_hospital_visit
Pai K, Salgaonkar G, Kudva R, Hedge P. Diagnostic Correlation Between PSA, Gleason Score and Bone Scan Results in Prostatic Cancer Patients with Bone Metastasis. British Biomedical Bulletin; 2015 [Disitasi pada 2018 Feb 8]; 3(1); 1-7. Tersedia di:
https://www.imedpub.com/articles/diagnostic-correlation-between-serum-psa-gleason-score-and-bone-scan-results-in-prostatic-cancer-patients-with-bone-metastasis.pdf
Altuwaijri S. Role of Prostatic Spesific Antigen (PSA) In Pathogenesis of Prostate Cancer. Journal of Cancer Therapy; 2012 [Disitasi pada 2017 June 7]; 3; 331-336. Tersedia di:
http:// dx.doi.org/10.4236/jct.2012.34043
Prasadja N, Hardjowijoto S, Pudjirahardjo JW. Hubungan PSA,PSAD dan skor Gleason pada penderita karsinoma prostat di RSUD Dr.Soetomo Surabaya periode tahun 2001 – 2007 RSUD Dr. Soetomo FK UNAIR Surabaya. 2007 [Disitasi pada 2018 Feb 7]. Tersedia di:
http://www.scribd.com/document/322551670/Hubungan-Psa-Dengan-Skor-Gleason-Pada-Karsinoma-Prostat
Akizhanova M, Iskakova EE, Kim V, Wang X, Kogay R, Turibayeva A, Sun Q, Zheng T, Wu S, Miao L, Xie Y. PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis. Journal of Cancer; 2017 [Disitasi pada 2017 June 4]; 8; 1223-1228. Tersedia di:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463437/.
Syafiie SH. Hubungan antara tumor associated-macrophages (TAMS), microvessel density (MVD), kadar prostatic specific antigen (PSA) dengan derajat histologis lesi prostat PIN high grade dan adenokarsinoma prostat. Tesis Fakultas Kedokteran Universitas Gadjah Mada Yogyakarta. 2014 [Disitasi pada 2017 Des 25]. Tersedia di:
http://etd.repository.ugm.ac.id/home/detail_pencarian/70909
Elabbady AA, Khedr MM. Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3–10 ng/ml. International Urology and Nephrology; 2006 [Disitasi pada 2018 Feb 8]; 38; 553-557. Tersedia di:
https://www.ncbi.nlm.nih.gov/pubmed/17171424
